Danielle Leek
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 8
- SARS-CoV-2 and COVID-19 Research 6
-
- Bacterial Identification and Susceptibility Testing 1
- Co-authors
- Julian Parkhill (8 shared papers)Sharon J. Peacock (9 shared papers)Kathy E. Raven (9 shared papers)Beth Blane (9 shared papers)Francesc Coll (3 shared papers)David Enoch (4 shared papers)Ewan M. Harrison (2 shared papers)Gwenan M. Knight (1 shared paper)
- Journals
- Nature Communications (2 papers)Microbial Genomics (2 papers)Nature (2 papers)Journal of Clinical Microbiology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United Kingdom
In The Last Decade
Danielle Leek
15 papers receiving 2.1k citations
Danielle Leek's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 1.9k
- Modeling and Simulation 81
- Clinical Biochemistry 19
- Molecular Medicine 25
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by Danielle Leek
This map shows the geographic impact of Danielle Leek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Leek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Leek more than expected).
Fields of papers citing papers by Danielle Leek
This network shows the impact of papers produced by Danielle Leek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Leek. The network helps show where Danielle Leek may publish in the future.
Co-authors
The 19 scholars most cited alongside Danielle Leek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 3 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 4 | 2021 | 228 | |
| 5 | 2020 | 115 | |
| 6 | 2022 | 31 | |
| 7 | 2019 | 14 | |
| 8 | 2019 | 14 | |
| 9 | 2022 | 13 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 9 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2022 | 2 |
About Danielle Leek
Danielle Leek is a scholar working on Infectious Diseases, Clinical Biochemistry, Modeling and Simulation, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 15 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 epidemiological studies (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (1.9k citations), Modeling and Simulation (81 citations), Clinical Biochemistry (19 citations), Molecular Medicine (25 citations) and Applied Microbiology and Biotechnology (8 citations). Danielle Leek has collaborated with scholars based in United Kingdom. Frequent co-authors include Julian Parkhill, Sharon J. Peacock, Kathy E. Raven, Beth Blane, Francesc Coll, David Enoch, Ewan M. Harrison, Gwenan M. Knight, Eugene Bragin and Narender Kumar. Their work appears in journals such as Nature Communications, Microbial Genomics, Nature, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.